Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,496.45 +9.42 (+0.17%) Dow
38,889.98 +55.12 (+0.14%) Nasdaq
17,894.35 +32.12 (+0.18%) Bitcoin USD
64,895.70 -18.39 (-0.03%) CMC Crypto 200
1,346.17 -36.49 (-2.64%)
NTRA Oct 2024 92.500 call
| Previous close | 21.73 |
| Open | 21.73 |
| Bid | 20.10 |
| Ask | 24.80 |
| Strike | 92.50 |
| Expiry date | 2024-10-18 |
| Day's range | 21.73 - 21.73 |
| Contract range | N/A |
| Volume | |
| Open interest | 17 |
GuruFocus.comInsider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
On June 17, 2024, Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), executed a sale of 6,105 shares of the company. The transaction was filed on June 18, 2024, as reported in the SEC Filing. Following this transaction, the insider now owns 213,351 shares of Natera Inc.
Business WireNatera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
AUSTIN, Texas, June 17, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of Prospera Heart™ with Donor Quantity Score (DQS), further enhancing Prospera’s ability to detect rejection in heart transplant patients.
Business WireNatera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
AUSTIN, Texas, June 03, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).
